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Abstract 
Purpose: To examine the gene expression profile, as well as blood sugar-lowering and lipid-lowering 
molecular mechanisms of Dendrobium mixtures in a diabetic rat model .  
Methods: Sprague Dawley (SD) rats were fed high-fat/high-glucose for 16 months. Those with random 
blood glucose > 16.7 mmol/L were used as the model group and treated with Dendrobium mixture 
(DEN, containing Dendrobium, Astragalus, Schisandra, etc) in clinically equivalent dose (12 g/kg). The 
liver RNA of the rats in all three groups (control, model and DEN) was used for Agilent genome 
expression microarray testing and subsequent data analysis. 
Result: Between the diabetic rat group and the wild-type group, 1339 functional genes showed 
differences in expression levels (p < 0.05). After Dendrobium treatment, only 380 genes showed 
differences in expression (p < 0.05). The expression level of nearly 1000 genes returned to normal after 
drug treatment (compared with the wild-type group, p > 0.05). Genes whose expression normalized 
were mainly those affected by the disease state and associated with glucose and lipid metabolism, cell 
growth, apoptosis, biosynthesis, olfactory receptors, or cytoskeletal proteins. 
Conclusion: Progressive therapy with Dendrobium mixture, which has glucose- and lipid-lowering 
effects, is associated with multi-gene expression pathways. By treating diabetic r and wild-type rats with 
the mixture, the disorder is further understood at the transcriptomic level.  
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With social and economic development, 
improvement in quality of life, and increasing life 
expectancy, diabetes mellitus (DM) has shown 
increasing prevalence, becoming a global health 
issue. Type 1 diabetes is a chronic autoimmune 
disease triggered by environmental factors, with 
islet B cell-specific injury; type 2 diabetes is due 
to insufficient insulin secretion or peripheral 
tissue insulin resistance, accounting for more 
than 95 % of cases in adult patients[1-2]. The 
pathogenesis of diabetes is unclear; although 
cellular and animal experiments, and clinical 
tests have shown that hypoglycaemic 
symptomatic treatment has a protective effect[3]. 
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Over the past decade, many studies have 
reported the use of traditional Chinese medicine 
(TCM) for the treatment of diabetes mellitus in 
clinical and experimental research. Gene chip, 
also called cDNA microarray, refers to the many 
specific gene fragments fixed to a solid support. 
The tagged samples are hybridized with the fixed 
fragment on the solid support. By confocal laser 
scanning fluorescence detection system, 
hybridization signal intensity is detected and the 
number of molecules and sequence information 
are obtained. Using computer software for data 
comparison and analysis, gene sequence and 
function are studied on a large-scale and high-
throughput [4]. Its purpose is to extract 
information from genes with an appropriate 
clustering method [5]. 
 
This study presents a theoretical basis for 
therapy of diabetes by searching for potential 




Experimental animals    
 
Seventy healthy female specific pathogen-free 
(SPF) SD rats, 12 weeks old, weighing 200 ± 20 
g, were provided by Slac Laboratory Animal 
(Shanghai, China). All animal experiments were 
performed in accordance with the approval 
received from the Institutional Animal Ethics 
Committee following the guidelines of the 
Committee for the Purpose of Control and 
Supervision of Experiments on Animals 
(CPCSEA), Government of China, and the 
International Guidelines for Handling of 




Dendrobium (Dendrobium officinale Kimura et 
Migo), belongs to the orchid species, and mainly 
distributed in tropical and subtropical Asia, 
Australia and the Pacific Islands, and the 
southern region of China. The plant material was 
collected from the wild in Fujian province in south 
China in April 2010 and authenticated by 
Associate Professor Chengzi Yang at the 
Department of Pharmacy, Fujian Medical 
University, Fuzhou, China; a voucher specimen 
(XQ-2010) was deposited in the herbarium of 
Integrative Medicine, Fujian University of 
Traditional Chinese Medicine, Fuzhou, China. 
The plant was dried to preserve it. 
 
Preparation of Dendrobium mixtures 
 
Dendrobium mixture 1 consisted of Dendrobium 
15 g, astragalus 15 g, Schisandra 20 g, salvia 20 
g, arrowroot 15 g, yam 10 g and dried rehmannia 
root 10 g; while Dendrobium mixture 2 consisted 
of Dendrobium 15 g , astragalus 20 g, 
Schisandra 10 g, salvia 10 g, arrowroot 15 g, 
dried rehmannia root 10 g, Scrophulariaceae 10 
g, Anemarrhena 10 g, habitat 10 g, gypsum, 20 
g, Cyathula 10 g, berberine 10 g. Dendrobium 
mixture 3 was composed of Capillaris 20 g, 
rhubarb 4 g, gardenia 10 g and Bupleurum 6 g. 
After mixing the ingredients of the formulation, it 
was soaked in 500 ml of water for 1 h and then 
boiled for one hour to brew. It was sterilized for 
20 min at 200 °C, 100 ml of the mixture was 
packed into separate glass bottles and kepted for 
gavage experiments. 
 
Pretreatment of animals 
 
The SD rats (12 weeks old) were adaptively fed 
for 7 days in the Fujian University of Traditional 
Chinese Medicine SPF level Animal Center 
Laboratory, and then randomly divided into two 
groups: 15 rats in the wild-type group and 55 rats 
in the high-fat/high-glucose group. The wild-type 
group was given a basic diet while the high-
fat/high-glucose group was given a high-fat/high-
glucose diet. The basic diet, obtained from Fujian 
Medical University Experimental Animal Center, 
composed of 19 % flour, 23 % corn flour, 6 
%sorghum flour, 10 % wheat bran, 20 % skim 
milk powder, 10 % fish meal, 7 % starch, 3 % 
glycine and 2 % of the beer yeast. The high-
fat/high-glucose diet was prepared to contain 15 
% sugar, 10 % lard, 4 % cholesterol, 0.3 % bile 
salts, 10 % egg yolk powder, and 60.7 % basic 
diet. The rats were continuously fed for 16 
months, and blood glucose monitored by a 
glucose meter. One wild-type rat and 4 high-
fat/high-glucose rats died during the test. If 
model generation failed (note: model generation 
succeeded if random blood glucose was ≥ 16.7 
mmol/L, and unsuccessful if < 16.7 mmol/L), then 
intraperitoneal injection of a low dose of 
streptozotocin (STZ) was given (20 mg/kg), 
under ice bath conditions, 0.25 % sodium citrate 
buffer (pH 4.2), prepared immediately prior to 
use). Successfully generated diabetic rats were 
selected 3 days later using a small-volume 
glucometer for blood sugar measurement. Low 
doses of STZ were injected into the remaining 
non-diabetic rats. Successfully generated model 
rats (random blood glucose ≥ 16 mmol/L) were 
again selected 3 days later and all diabetic rats 
were randomly divided into the diabetic rat model 
group and Dendrobium mixture group. 
 
Treatment of animals 
 
Initially, the Dendrobium mixture (DEN) was 
gavag to the DEN treatment group at a dos of 12 
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g/(kg /d) (clinically equivalent dose): Dendrobium 
mixtures (DEN) 1 and 2 were administered for 6 
days and 12 days to the DEN treatment group, 
respectively. Thereafter, the rats were fed DEN 3 
for 3 days as a course of treatment. The animals 
were allowed a wahout for a day in-between the 
treatment types. Two courses of treatment (DEN 
1、2 and) were conducted over a total period of 
48 days.  
 
After two dosage cycles (DEN 1, 2 and 3 twice 
each), the rats were fasted overnight and 
anesthetized using 1 % urethane after first 
weighing them. Rapid laparotomy was then 
performed, liver tissue was removed and stored 
in liquid nitrogen. Tissue samples were removed 
in this way from randomly selected rats in each 
of the wild-type, diabetic model, and treatment 
groups and sent to Shanghai Biotechnology Co, 
Ltd for Agilent Whole Rat Genome Oligo 
Microarray (4 × 44K) testing. 
 
Total RNA extraction and quality control  
 
Total RNA was extracted from 1 g of liver tissue 
using 2 ml Trizol reagent following the standard 
protocols provided by the manufacturer of the 
reagent. After passing the Agilent Bioanalyzer 
2100 electrophoresis quality assessment, 
RNeasy mini-kit and RNase-free DNase kit were 
used to purify the total RNA. If RNA quality 
control result for 2100 RIN and 28S/18S was ≥ 
7.0 and ≥ 0.7, respectively, then the test sample 




Sample RNA was treated with an Agilent 
microarray matching kit and a single-color Low 
Input Quick Amp Labeling Kit. The mRNA of the 
total RNA sample was amplified and labeled 
using standard protocols, and then labeled cRNA 
purified with an RNeasy mini kit. According to the 
standard protocol provided by the Agilent Gene 
Expression Hybridization Kit, hybridization 
reactions were rotated for 17 h in a rotating 
hybridization oven at 65 °C and 10 rpm. A 
sample (1.65 μg) of hybridized cRNA was 
obtained and washed. The the hybridized chip 
was scanned in an Agilent Microarray Scanner 
and the Gene Spring Software 11.0 (Agilent 
Technologies, Santa Clara, CA, U.S.) was 





The online SAS analysis system (at Shanghai 
Biotechnology Co, Ltd) was used for 
bioinformatics analysis. The R-package within 
the software package was used for statistical 
analysis. The samples from the three groups 
were compared using single-factor analysis of 
variance (one-way ANOVA). Pairwise 
comparisons between groups were performed 
with multiple comparisons Dunnett-t test. 
Significant differences were filtered by setting the 
p-value at < 0.05, and the FC (fold change, also 
called difference factor) value calculated. A given 
gene was categorized as upregulated when FC ≥ 
2 and as downregulated when FC ≤ 0.5. The 
result file was used for database comparison and 
comments. The basic annotation and information 
for various genes were taken from the NCBI 
Entrez Gene database (http://www.ncbi.nlm 
.nih.gov/gene/) while the gene pathway data 
were taken from KEGG (http://www.genome. 





The differences in expression of all genes in the 
two groups are displayed on a scatter plot (Fig 
1). The X and Y axes are coordinates of the 
fluorescence signal intensity value of the two 
samples, each data point represents a gene 
hybridization signal on the chip. Signals that 
showed differential expression fell outside of the 
parallel lines, where fold change was > 2. The 
left-side data points outside of the parallel lines in 
the left figure reflect increased gene expression 
in the model and wild-type groups while data 
points to the right reflect downregulation. The 
data points on the left side of the parallel lines 
indicate increased expression of genes between 
the model and treatment groups, while data 
points to the right side show down-regulated 
expression of the genes. 
 
 
Fig 1: Scatterplot constructed with GeneSpring 11.0. 
Note: Model = rat model group; medication = 
treatment group, and control = wild-type control group 
 
As a result, 1678 differentially expressed genes 
(p < 0.05) were identified between the wild-type 
and diabetic model groups. Of these, the 
functions of 1339 are known while those of 399 
are unknown. Of the genes originally displaying 
FC > 2, 78 were downregulated and 182 
upregulated. There were 1107 differentially 
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expressed genes (p < 0.05) identified between 
the treatment and the model groups. Of these, 
the functions of 671 are known and those of 336 
are unknown. Among the genes originally 
displaying FC > 2, 32 were subsequently 
downregulated and 277 upregulated. There were 
665 differentially expressed genes identified 
between the treatment and the wild-type groups 
(p < 0.05). Of these, 380 are known genes and 
285 are unknown. Among genes subjected to 
pre-treatment FC > 2, 20 were found to have 
been downregulated and 59 upregulated.  
 
Overall, pairwise comparison for the three groups 
indicates that post-treatment diabetic rats 
expressed about 1,000 genes near wild-type 
levels, but the difference was not statistically 
significant (p > 0.05). The expression levels of 
these genes were considered to have been 
corrected. A few genes displayed post-treatment 
directionality of regulation similar to that 
observed in the diabetic group, but their 
differences in expression level relative to the 
wild-type group were equal to or less than their 
differences in expression level from the diabetic 
group. In addition, no genes displaying growth 
bias were found. Tables 1 and 2 show the 
correction of the down- and up-regulated genes 
in the treatment group (p < 0.05). Fig.2 shows 




Table 1: Down-regulation in diabetic rat model indicating normally regulated genes after dendrobium mixture 
treatment 
 
Gene Abbreviation Gene Id Chromosome FC 
SH3 and cysteine rich domain 3 Stac3 362895 7 0.0203 
Stearoyl-CoA desaturase (delta-9-desaturase) Scd 83792 1 0.0739 
Major urinary protein 5 Mup5 298107 5 0.1126 
Alpha-2u globulin PGCL3 LOC259244 259244 5 0.1426 
Patatin-like phospholipase domain containing 5 Pnpla5 300108 7 0.1755 
Similar to major urinary protein 5 LOC685577 685577 5 0.1926 
Torsin family 3,  member A Tor3a 304884 13 0.2265 
Similar to RIKEN cDNA B130016O10 gene RGD1308448 310358 2 0.2497 
Note: Gene Id represents the identity (ID) of the gene in GenBank; FC = model group gene expression level/wild-type group 
expression level; genes with FC < 0.25 are listed in this table. With respect to chromosomal localization, “-” indicates multiple 
chromosomal locations for a single gene; “Un” indicates unknown 
 
Table 2: Up-regulation in diabetic rat model after administration of Dendrobium mixture indicating genes that 
show normal expression 
 
Gene  Abbreviation Gene Id Chromosom
e 
FC 
Glyoxalase domain containing 5 Glod5 302554 X 17.3097 
Regulator of G-protein signaling 4 Rgs4 29480 13 11.8168 
Protein phosphatase 2, regulatory subunit B, beta isoform Ppp2r2b 60660 18 8.7967 
Similar to TGF beta-inducible nuclear protein 1 (LNR42) LOC679999 679999 X 8.1652 
Heat shock protein 1 Hspb1 24471 12 7.8923 
Ring finger protein 186 Rnf186 690433 5 7.4041 
Glutathione peroxidase 2 Gpx2 29326 6 5.4068 
Follistatin Fst 24373 2 5.1331 
Brain expressed gene 1 Bex1 501625 X 4.5534 
Gamma-glutamyltransferase 1 Ggt1 116568 - 4.55 
Integrin,  beta 6 Itgb6 311061 3 4.3516 
WNT1 inducible signaling pathway protein 2 Wisp2 29576 3 4.2208 
Glypican 3 Gpc3 25236 X 4.1231 
Note: Gene Id represents the ID of the gene in GenBank; FC = model group gene expression level/wild-type group expression 
level; genes with FC > 4 are listed in this table; with respect to chromosomal localization, “-” indicates multiple chromosomal 
locations for a single gene; “Un” indicates unknown. 
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Fig 2: Comparison of chromosomal localization of 
genes in the wild-type, rat model, and treatment 
groups (ANOVA analysis, p < 0.05). Note: Red colour 
indicates individual genes, yellow partially indicates 
gene-rich regions, and “un” indicates unknown genes 




Traditional Chinese medicine (TCM) considers 
the organic defects of type 2 diabetes to be 
located mainly in the stomach, liver, and kidneys 
with some involvement from the cardiopulmonary 
system. The basic theory of TCM includes five-
zang organs and six fuorgans, vital energy (Qi), 
blood, and meridians (Jingluo). TCM drug 
treatment typically consists of a complex 
prescription of multiple components based on 
differentiation of symptoms and signs (zheng), 
including Yin, Yang, exterior (biao), interior (li), 
cold (han), heat (re), deficiency (xu), and excess 
(shi). Diabetes is categorized by TCM as a mixed 
disorder involving weakness conditions and 
presenting conditions in multiple areas. The two 
main weakness conditions involve Qi or both Qi 
and Yin, while the presenting conditions involve 
inner heat, stasis, and turbidity. Previous 
research indicates that Dendrobium mixtures can 
improve Yin, soothe inner heat, and replenish the 
kidney [7]. It has also been found to significantly 
improve lung and kidney function in STZ rat 
model. DEN 1 improved Yin and Qi, enhanced 
circulation, strengthened the spleen, replenishes 
the kidneys, and reduces inner heat. DEN 2 
strengthened life serum, reduced inner heat, and 
prevented excessive heating. DEN 3 nourishes 
Yin, reduced humidity and turbidity, and expelled 
humid heat through the beneficial effect on 
phlegm and inner heat. We tested the clinically 
effective drugs in diabetic rat models and 
treatment group with wild-type group as well as 
between treated and untreated model groups. In 
this way, target genes can be identified 
accurately. Corrected genes were mainly related 
to metabolic processes, immune processes, cell 
growth, apoptosis, signal transduction, 
carbohydrate synthesis, carbohydrate 
degradation, transcription regulation, olfactory 
receptors, the microtubule system, and the 
nervous system. 
The CD gene family and toll-like receptor-9 
protein (TLR9) were affected by the treatment. 
Both human and rodent TLR9 have 77 % 
homology. TLR9 signal transduction ultimately 
activates transcription factors such as NF2κB, 
AP21 and CREB, and these transcription factors 
increase expression of various cytokines and 
chemokine, thereby promoting the proliferation of 
B cells and activating macrophages. In this way, 
it plays an important innate immune defense 
against pathogens [8,9]. Migita et al used flow 
cytometry to determine that B lymphocyte TLR9 
is up-regulated in autoimmune diseases 
(systemic lupus erythematosus and autoimmune 
hemolytic anemia) [10]. Christensen et al have 
shown that TLR9-deficient mice produce 
increasing amounts of IFNα and show enhanced 
immune activation, increased Lupus nephritis, 
and increased mortality [11]. Our study found 
that TLR9 receptors in diabetic rats had low 
expression but returned to normal levels after 
treatment. This indicates that Dendrobium 
mixture (DEN) can improve autoimmune activity 
in diabetic rats, thereby enhancing the ability of 
the body to counter external pathogens and 
stimuli. 
 
Our study also found a variety of receptors in the 
CD (cluster of differentiation) gene family with 
increased levels of expression in the liver of 
diabetic rats, such as CD24 (FC = 3.16), CD38 
(FC = 1.30), CD74 (FC = 1.55), CD44 (FC = 
1.97). The expression level normalized after 
Dendrobium mixture treatment, compared with 
normal group. CD molecules are widely involved 
in immune cell recognition of antigens, act as 
receptors for certain immune-active substances, 
mediate adhesion between cells and matrix, 
mediate immune response, and are involved in 
inflammation, hematopoietic regulation, wound 
healing, blood clotting, tumor metastasis, and 
other important physiological and pathological 
processes[12-15]. CD24 may participate in tumor 
development by promoting tumor cell 
proliferation, invasion, and metastasis. It has 
become a prognostic sign, and indicator of 
invasion and metastasis for certain malignant 
tumors [12].  
 
CD38 molecule is an indicator for chronic B 
lymphocytic leukemia, a diagnostic criterion for 
reactive autoimmune diabetes. It can be used for 
the detection of AIDS and cytomegalovirus, and 
to monitor the condition of patients with systemic 
lupus erythematosus [13]. CD74 is a cell 
membrane receptor of macrophage migration 
inhibitory factor (MIF). It has been found to be 
over-expressed in a variety of cancer tissues 
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Xu et al 
Trop J Pharm Res, April 2013;12 (2): 
 
7 
[14]. Abnormal expression of CD44 is considered 
to be a biological marker in tumors, early stages 
of cancer, and cancer metastasis [15]. 
Overexpression of CD proteins in diabetic 
patients provides a fertile environment for tumor 
growth and differentiation. Dendrobium mixture 
therapy not only changed gene expression 
patterns in type 2 diabetes but also improved 
immune activity and reduced the likelihood of 
cancer development. 
 
Genes that are down-regulated in rats in vivo 
include L-leucine hydrolase, amine oxidase, low-
density lipoprotein receptor-related protein 5, and 
ATP enzyme (Atp6nl). ATP enzyme is up-
regulated in rats considered systemically cool by 
TCM and down-regulated in rats considered 
systemically warm by TCM [16]. In our study, the 
ATP enzyme Atp13a1 protein is down-regulated 
(0.3939) and displays a possible TCM 
association with extreme heat due to deficiency 
of Yin, indicating that Dendrobium mixtures can 
regulate agitated inner heat. Also overexpressed 
in rats are G proteins and their regulatory 
proteins, cytochrome P450, glutathione 
peroxidase, O-acyltransferase membrane-
binding domain, lipoprotein lipase, cytidine 
deaminase, dimethyl amino hydrolase, protein 
tyrosine acid phosphatase, and Tspan8 protein.  
 
In 2008, more than 40 United States and 
European Institutes conducted genetic analyses 
of 70,000 diabetes patients and found six novel 
genes related to type 2 diabetes. These can be 
used as molecular markers of diabetes. One of 
those six genes was Tspan8 [17]. In our 
experiment, a three-fold increase in Tspan8 
expression was observed in the diabetic rat 
group. This is consistent with previous studies 
[17]. Normal expression of Tspan8 was restored 
after drug treatment, confirming this gene as one 
of the target sites for Dendrobium mixture 
treatment.  
 
Glutathione peroxidase 2 (Gpx2) is an important 
antioxidant enzyme which can remove excess 
peroxides, lipids, and phospholipid-free radicals, 
and can protect cell membranes and DNA [18]. 
Gpx2 was found in the present study to be 
overexpressed in diabetic rats (5.4068 fold). 
Gamma glutamyl transferase (GGT1) is one of 
the most important indicators of liver function. 
Excessive consumption of protein supplements 
can increase liver burden, leading to elevated 
GGT [19]. This gene has 4.55-fold higher 
expression in model rats, which is consistent with 
the results of other clinical studies. The 
expression of GGT normalized after treatment, 
indicating that Dendrobium mixture is 
hepatoprotective. 
WNT1 signaling pathway protein 2 (Wisp2) has 
been proven to play a key role in a number of 
cancers. Glypican 3 (Gpc3) has also been 
implicated in a variety of cancers such as ovarian 
and liver cancers. Deleted in malignant brain 
tumors 1 protein (DMBT1) is also associated with 
a variety of cancers. Heat shock protein beta1 is 
associated with cancer cell metastasis and 
photo-oxidized aging of the skin. Keratin has 
been confirmed to be associated with colorectal 
carcinoma. Fibulin-like extracellular matrix 
protein 1 (fibulin1) and Fxyd3 protein have been 
confirmed as overexpressed in gastric 
adenocarcinoma, colorectal cancer, pancreatic 
cancer, and other tissue cancers [20, 21]. A 
number of apoptosis- and cancer-related genes 
showed increased expressions in the liver of rats, 
indicating that the Dendrobium mixture helped to 





TCM herbal remedies are complex in 
composition and not all of the resulting molecular 
effects on different organisms have been 
elucidated. Further study into the genetic 
polymorphisms and validation of protein function 
of our screened divergent genes will help 
researchers identify new targets for TCM 
treatment of type 2 diabetes and lay a firm 
foundation for molecular diagnosis of clinical 
diabetes and integrated TCM-Western medical 
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